Once in the bloodstream, LPS triggers systemic inflammation and contributes to endothelial dysfunction by upregulating inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Here, TNF is linked to endothelial dysfunction.